Locations:
Search IconSearch
May 25, 2018/Cancer/Research

ASCO 2018 – Friday, June 1

Please join our staff as we participate or present in the following oral and poster presentations at the 2018 ASCO Annual Meeting

#ASCO_650x450

Friday, June 1

2:45-3:05 p.m.
Hall D1
EDUCATION SESSION:
My Patient Was Diagnosed with Nontargetable
Advanced Non-Small Cell Lung Cancer: What Now?

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Assessment and diagnostics of newly diagnosed
patients with advanced non-small cell lung cancer
Nathan Pennell, MD, PhD – Speaker

3:05-3:25 p.m.
S100bc
EDUCATION SESSION:
Personalizing Postoperative Treatment for Head
and Neck Cancer Nodal disease in HPV-positive and HPV-negative
cancer: Who needs postoperative radiation?
Shlomo Koyfman, MD – Speaker

3:25-3:45 p.m.
E253c
CLINICAL PROBLEMS IN ONCOLOGY SESSION:
When Less Is More: Local-Regional Management
of Breast Cancer Is abbreviated radiation a reality?
Chirag Shah, MD – Speaker

3:45-3:57 p.m.
S102
ORAL ABSTRACT SESSION:
ALLELE: A consortium for prospective genomics
and functional diagnostics to guide patient care
and trial analysis in newly-diagnosed glioblastoma
Abstract 2003
Manmeet Ahluwalia, MD – Author

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

24-CNR-4545611-CQD-Podcast-967×544
February 1, 2024/Cancer/Research
Possibilities of CRISPR Technology (Podcast)

Gene editing technology offers promise for treating multiple myeloma and other hematologic malignancies, as well as solid tumors

Disparities in multiple myeloma
January 25, 2024/Cancer/Research
Major Study Identifies Global Disparities in Drug Toxicity for Multiple Myeloma Treatment

Study of 401,576 patients reveals differences in cancer burdens as well as overall survival

Dr. Shilpa Gupta
December 27, 2023/Cancer/Research
A New Standard Emerges in Advanced Urothelial Carcinoma After Decades of First-Line Chemotherapy

Enfortumab plus pembrolizumab reduced risk of death by 53% compared with platinum-based chemotherapy

Ad